These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 19037236)

  • 1. Transient anti-CD40L co-stimulation blockade prevents immune responses against human bullous pemphigoid antigen 2: implications for gene therapy.
    Lanschuetzer CM; Olasz EB; Lazarova Z; Yancey KB
    J Invest Dermatol; 2009 May; 129(5):1203-7. PubMed ID: 19037236
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transcutaneous gene gun delivery of hNC16A Induces BPAG2-specific tolerance.
    Ettinger M; Peckl-Schmid D; Gruber C; Laimer M; Thalhamer J; Hintner H; Gratz IK; Bauer JW
    J Invest Dermatol; 2012 Jun; 132(6):1665-71. PubMed ID: 22377765
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Noncollagenous 16A domain of type XVII collagen-reactive CD4+ T cells play a pivotal role in the development of active disease in experimental bullous pemphigoid model.
    Ujiie H; Shibaki A; Nishie W; Shinkuma S; Moriuchi R; Qiao H; Shimizu H
    Clin Immunol; 2012 Feb; 142(2):167-75. PubMed ID: 22044750
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human bullous pemphigoid antigen 2 transgenic skin elicits specific IgG in wild-type mice.
    Olasz EB; Roh J; Yee CL; Arita K; Akiyama M; Shimizu H; Vogel JC; Yancey KB
    J Invest Dermatol; 2007 Dec; 127(12):2807-17. PubMed ID: 17657247
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Host CD40 ligand deficiency induces long-term allograft survival and donor-specific tolerance in mouse cardiac transplantation but does not prevent graft arteriosclerosis.
    Shimizu K; Schönbeck U; Mach F; Libby P; Mitchell RN
    J Immunol; 2000 Sep; 165(6):3506-18. PubMed ID: 10975872
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sequential intramolecular epitope spreading of humoral responses to human BPAG2 in a transgenic model.
    Di Zenzo G; Calabresi V; Olasz EB; Zambruno G; Yancey KB
    J Invest Dermatol; 2010 Apr; 130(4):1040-7. PubMed ID: 19812601
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glucocorticoid-induced TNFR-related protein stimulation reverses cardiac allograft acceptance induced by CD40-CD40L blockade.
    Krill KT; Csencsits-Smith K; Wood SC; Faust S; Lu G; Bishop DK
    Clin Dev Immunol; 2013; 2013():986859. PubMed ID: 23690829
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Murine Fibroblastic Reticular Cells From Lymph Node Interact With CD4+ T Cells Through CD40-CD40L.
    Nakayama Y; Brinkman CC; Bromberg JS
    Transplantation; 2015 Aug; 99(8):1561-7. PubMed ID: 25856408
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aggressive skin allograft rejection in CD28-/- mice independent of the CD40/CD40L costimulatory pathway.
    Ha J; Bingaman AW; Durham MM; Pearson TC; Larsen CP
    Transpl Immunol; 2001 Oct; 9(1):13-7. PubMed ID: 11680567
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CD40 ligand-specific antibodies synergize with cyclophosphamide to promote long-term transplantation tolerance across MHC barriers but inhibit graft-vs-leukemia effects of transplanted cells.
    Prigozhina TB; Gurevitch O; Elkin G; Morecki S; Yakovlev E; Slavin S
    Exp Hematol; 2003 Jan; 31(1):81-8. PubMed ID: 12543110
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immune Reaction to Type XVII Collagen Induces Intramolecular and Intermolecular Epitope Spreading in Experimental Bullous Pemphigoid Models.
    Ujiie H; Yoshimoto N; Natsuga K; Muramatsu K; Iwata H; Nishie W; Shimizu H
    Front Immunol; 2019; 10():1410. PubMed ID: 31275329
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Suppression of the immune response against exogenous desmoglein 3 in desmoglein 3 knockout mice: an implication for gene therapy.
    Ohyama M; Ota T; Aoki M; Tsunoda K; Harada R; Koyasu S; Nishikawa T; Amagai M
    J Invest Dermatol; 2003 Apr; 120(4):610-5. PubMed ID: 12648224
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Blockade of CD40-mediated signaling is sufficient for inducing islet but not skin transplantation tolerance.
    Phillips NE; Markees TG; Mordes JP; Greiner DL; Rossini AA
    J Immunol; 2003 Mar; 170(6):3015-23. PubMed ID: 12626555
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-lymphocyte function-associated antigen-1 monoclonal antibody inhibits CD40 ligand-independent immune responses and prevents chronic vasculopathy in CD40 ligand-deficient mice.
    Corbascio M; Mahanty H; Osterholm C; Qi Z; Pearson TC; Larsen CP; Freise CE; Ekberg H
    Transplantation; 2002 Jul; 74(1):35-41. PubMed ID: 12134096
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CD4+ T lymphocytes expressing CD40 ligand help the IgM antibody response to soluble pneumococcal polysaccharides via an intermediate cell type.
    Jeurissen A; Billiau AD; Moens L; Shengqiao L; Landuyt W; Wuyts G; Boon L; Waer M; Ceuppens JL; Bossuyt X
    J Immunol; 2006 Jan; 176(1):529-36. PubMed ID: 16365447
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Blockade of CD40/CD40 ligand interactions prevents induction of factor VIII inhibitors in hemophilic mice but does not induce lasting immune tolerance.
    Reipert BM; Sasgary M; Ahmad RU; Auer W; Turecek PL; Schwarz HP
    Thromb Haemost; 2001 Dec; 86(6):1345-52. PubMed ID: 11776297
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CD40 ligand blockade induces CD4+ T cell tolerance and linked suppression.
    Honey K; Cobbold SP; Waldmann H
    J Immunol; 1999 Nov; 163(9):4805-10. PubMed ID: 10528180
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 4-1BB promotes long-term survival in skin allografts treated with anti-CD45RB and anti-CD40L monoclonal antibodies.
    Lee J; Lee EN; Kim EY; Lee HJ; Park HJ; Sun CL; Lee SK; Joh JW; Lee KW; Kwon GY; Kim SJ
    Transplant Proc; 2005; 37(1):123-5. PubMed ID: 15808569
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Disruption of CD40/CD40-ligand interactions in a retinal autoimmunity model results in protection without tolerance.
    Bagenstose LM; Agarwal RK; Silver PB; Harlan DM; Hoffmann SC; Kampen RL; Chan CC; Caspi RR
    J Immunol; 2005 Jul; 175(1):124-30. PubMed ID: 15972638
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Blistering insights into the pathogenesis of bullous pemphigoid.
    Wong HK; Bechtel MA
    Clin Immunol; 2012 Feb; 142(2):101-4. PubMed ID: 22217422
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.